Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 23

Driven by genetic and environmental factors, aging is a physiological process responsible for age-related degenerative changes in the body, cognitive decline, and impaired overall wellbeing. Notably, premature aging as well as the emergence of progeroid syndromes have posed concerns regarding chronic health conditions and comorbidities in the aging population. Accelerated telomere attrition is also implicated in metabolic dysfunction and the development of metabolic disorders. Impaired metabolic homeostasis arises secondary to age-related increases in the synthesis of free radicals, decreased oxidative capacity, impaired antioxidant defense, and disrupted energy metabolism. In particular, several cellular and molecular mechanisms of aging have been identified to decipher the influence of premature aging on metabolic diseases. These include defective DNA repair, telomere attrition, epigenetic alterations, and dysregulation of nutrient-sensing pathways. The role of telomere attrition premature aging in the pathogenesis of metabolic diseases has been largely attributed to pro-inflammatory states that promote telomere shortening, genetic mutations in the telomerase reverse transcriptase, epigenetic alteration, oxidative stress, and mitochondrial dysfunctions. Nonetheless, the therapeutic interventions focus on restoring the length of telomeres and may include treatment approaches to restore telomerase enzyme activity, promote alternative lengthening of telomeres, counter oxidative stress, and decrease the concentration of pro-inflammatory cytokines. Given the significance and robust potential of delaying telomere attrition in age-related metabolic diseases, this review aimed to explore the molecular and cellular mechanisms of aging underlying premature telomere attrition and metabolic diseases, assimilating evidence from both human and animal studies.

Aging is defined as a physiological phenomenon driven by genetic and biological processes, which are related to the lifespan of an individual and are associated with all age-related pathologies (Li et al., 2021). The aging process increases the susceptibility of individuals to factors leading to death as they grow older. Aging is a complex multifactorial phenomenon that involves the simultaneous interaction between various factors at different levels of functional organization. The role of genetic and environmental factors is represented by the heterogenous aging phenotype across different individuals, hence, these factors influence the lifespan of an individual via the process of aging (Jayanthi et al., 2010). With the deterioration of physiological functions critical to the survival and fertility of humans, the process of aging is known to relate to the notion of natural selection (Gilbert, 2000).

Read more | >

Chronic pain—or pain that lasts at least three months—is closely intertwined with depression. Individuals living with pain’s persistent symptoms may be up to four times more likely to experience depression, research shows.

Almost 30% of people worldwide suffer from a chronic pain condition such as and migraines, and one in three of these patients also report co-existing pain conditions.

Now, a new study published in Science Advances shows that a person’s risk of depression increases alongside the number of places in the body in which they experience pain. Furthermore, inflammatory markers such as C-reactive protein (a protein produced by the liver in response to inflammation) help explain the association between pain and depression.

Read more | >

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer’s disease (AD). The study, led by Director C Justin LEE, of the IBS Center for Cognition and Sociality, provides critical insights into how astrocytes contribute to cognitive decline by producing excessive amounts of the inhibitory neurotransmitter GABA.

Astrocytes, once thought to only support neurons, are now known to actively influence brain function. In Alzheimer’s disease, astrocytes become reactive, meaning they change their behavior in response to the presence of amyloid-beta (Aβ) plaques, a hallmark of the disease. While astrocytes attempt to clear these plaques, this process triggers a harmful chain reaction. First, they uptake them via autophagy (Kim and Chun, 2024) and degrade them by the urea cycle (Ju et al, 2022), as discovered in previous research. However, this breakdown results in the overproduction of GABA, which dampens brain activity and leads to memory impairment. Additionally, this pathway generates hydrogen peroxide (H2O2), a toxic byproduct that causes further neuronal death and neurodegeneration.

Read more | >

The skin is the largest organ in the human body. It makes up around 15 percent of our body weight and protects us from pathogens, dehydration and temperature extremes. Skin diseases are therefore more than just unpleasant – they can quickly become dangerous for affected patients. Although conditions such as skin cancer, chronic wounds and autoimmune skin diseases are widespread, we often still don’t fully understand about why they develop and how we can treat them effectively.

To find answers to these questions, Empa researchers are working together with clinical partners on a model of human skin. The model will allow scientists to simulate skin diseases and thus better understand them. This is not a computer or plastic model. Rather, researchers from Empa’s Laboratory for Biomimetic Membranes and Textiles and its Laboratory for Biointerfaces aim to produce a living “artificial skin” that contains cells and emulates the layered and wrinkled structure of human skin. The project is part of the Swiss research initiative SKINTEGRITY.CH.

In order to recreate something as complex as skin, suitable building materials are needed. This is where Empa researchers have recently made progress: They have developed a hydrogel that meets the complex requirements while being easy to manufacture. The basis: gelatin from the skin of cold-water fish.

Read more | >

Ubiquinone, a metabolite critical to generating energy in cells, has long been thought to be the only mitochondrial electron transport chain carrier in mammals. Although other electron transporters have been identified in bacteria, nematodes and other organisms, evidence of their presence in mammals has remained elusive.

Thanks to new high-resolution mass spectrometry technology, Jessica Spinelli, Ph.D., assistant professor of molecular medicine, has identified rhodoquinone as another fundamental electron transporter in the mammalian electron transport chain. The research was recently published in Cell.

Because rhodoquinone allows mitochondria to function in a low oxygen environment, Dr. Spinelli research may have clinical potential for protecting cells from hypoxia.

Read more | >

A breakthrough by researchers at The University of Manchester sheds light on one of nature’s most elusive forces, with wide-reaching implications for medicine, energy, climate modeling and more. The researchers have developed a method to precisely measure the strength of hydrogen bonds in confined water systems, an advance that could transform our understanding of water’s role in biology, materials science, and technology.

The work, published in Nature Communications, introduces a fundamentally new way to think about one of nature’s most important but difficult-to-quantify interactions.

Hydrogen bonds are the invisible forces that hold water molecules together, giving water its unique properties, from high boiling point to , and enabling critical biological functions such as protein folding and DNA structure. Yet despite their significance, quantifying in complex or confined environments has long been a challenge.

Read more | >

Recent advancements in in-vitro gametogenesis (IVG) suggest that lab-grown eggs and sperm could become viable within the next decade. This technology holds the promise of revolutionizing fertility treatments, particularly for individuals facing infertility and same-sex couples desiring biological children. However, it also raises significant ethical and medical considerations that must be carefully addressed.

The Human Fertilisation and Embryology Authority (HFEA), the UK’s fertility regulator, has reported that the development of lab-grown gametes, known as in-vitro gametogenesis (IVG), may become a practical option within the next decade. This technology involves creating eggs and sperm from reprogrammed skin or stem cells, potentially transforming fertility treatments by removing age-related barriers and enabling same-sex couples to have biological children.

IVG represents a significant advancement in reproductive science. By generating gametes in the laboratory, scientists can overcome challenges associated with traditional fertility treatments. This approach could provide new avenues for individuals with infertility issues and offer same-sex couples the opportunity to have children genetically related to both partners.

Read more | >

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor microenvironment, known as the stroma, which makes up the majority of the tumor mass and consists of a network of proteins and different non-tumor cells. Among these, fibroblasts play a key role, helping tumor cells to grow and increasing their resistance to drugs.

Now, a study led by researchers from the Hospital del Mar Research Institute, IIBB-CSIC-IDIBAPS, Mayo Clinic, Instituto de Biología y Medicina Experimental (CONICET, Argentina) and CaixaResearch Institute, has identified a new key factor contributing to this feature of : a previously unknown function of Galectin-1 protein inside the nuclei of fibroblasts.

This discovery, published in the journal PNAS, offers new insights into the role of these cells in the progression of pancreatic cancer.

Read more | >

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 vaccines not only induce acquired immune responses such as antibody production, but also cause persistent epigenetic changes in innate immune cells.

The study, “Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages,” led by Professor Dr. Jan Rybniker, who heads the Division of Infectious Diseases at University Hospital Cologne and is a principal investigator at the Center for Molecular Medicine Cologne (CMMC), and Dr. Robert Hänsel-Hertsch, principal investigator at the CMMC, was published in Molecular Systems Biology.

The immune system comprises two immunity strategies: the innate and the acquired (adaptive) immune system. The innate immune system provides general protection from pathogens and must react quickly. The adaptive immune system adapts to new pathogens and is highly specific in its response. Both systems work closely together.

Read more | >

A new high-tech implant has shown “promise” in fighting some of the deadliest forms of cancer.

The cancer-fighting device safely triggers “potent” immune responses against hard-to-treat cancers, including metastatic melanoma, and pancreatic and colorectal tumors, say American scientists.

A team of researchers from the Rice Biotech Launch Pad at Rice University in Houston developed the implantable “cytokine factory”

Read more | >